Market Overview

Why CNS Pharmaceuticals Is Trading Higher Today


CNS Pharmaceuticals (NASDAQ: CNSP) shares are trading higher on Monday.

The company announced that independent research from the University of Frankfurt showed that an active compound in WP1122 completely prevented coronavirus replication in vitro.

CNS Pharmaceuticals is a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors.

CNS Pharmaceuticals shares were trading up 9.28% at $3.65 on Monday. The stock has a 52-week high of $5.69 and a 52-week low of $1.26.


Related Articles (CNSP)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at